Finanzwire Finanzwire
Basculer en Français
10680 Companies
228005 Keywords
156514 Articles
120875 Press releases
Headlines Articles Press releases THERAVET Remove
  1. Home
  2. Companies
  3. THERAVET
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/07/2025 at 20:02, 1 year 3 months ago

    EGEIRO Pharma declares bankruptcy after decision of the Board of Directors

    Bankruptcy TheraVet Reverse Acquisition EGEIRO Pharma Suspension Of Actions
  • BRIEF

    published on 09/30/2024 at 07:35, 1 year 9 months ago

    TheraVet Announces Strategic Shift to Idiopathic Pulmonary Fibrosis

    Restructuring Phase II TheraVet H4Orphan Pulmonary Fibrosis
  • PRESS RELEASE

    published on 09/30/2024 at 07:30, 1 year 9 months ago

    Inside Information / Operations of the issuer (acquisitions, sales...)

    TheraVet and H4Orphan collaborate on a strategic project to create a leader in idiopathic pulmonary fibrosis, focusing on innovative treatments. Shareholders to vote on Operation in October 2024
    Shareholders Vote Strategic Project TheraVet H4Orphan Idiopathic Pulmonary Fibrosis
    Logo of THERAVET
  • PRESS RELEASE

    published on 09/12/2024 at 07:30, 1 year 9 months ago

    Inside Information / Other news releases

    TheraVet announces 2024 half-year results with positive sales growth and reduced operating loss. Company focuses on refinancing options and operational milestones
    Sales Growth Refinancing Operating Loss 2024 Half-year Results TheraVet
    Logo of THERAVET
Accesswire
  • Published on 07/03/2026 at 23:00, 1 day 2 hours ago

    Eagle Plains Partner Refined Energy Announces Final Results for Winter 2026 Drill Program at Dufferin West

  • Published on 07/03/2026 at 23:00, 1 day 2 hours ago

    Medicure Announces CFO Change

  • Published on 07/03/2026 at 21:28, 1 day 4 hours ago

    Trifecta Gold Announces Closing of $1.66 Million Private Placement

  • Published on 07/03/2026 at 19:30, 1 day 6 hours ago

    Polaris Renewable Energy Announces Q2 2026 Investor Call Details

  • Published on 07/03/2026 at 13:30, 1 day 12 hours ago

    Nextech3D.ai Unveils Strategic AI Growth Roadmap Focused on Workforce Intelligence and Event Technology Innovation

View all ACCESSWIRE
EQS Group
  • Published on 07/04/2026 at 17:35, 8 hours 4 minutes ago

    Vantage Introduces 24/7 Gold CFD Trading with XAUUSD247

  • Published on 07/04/2026 at 11:01, 14 hours 37 minutes ago

    EQS-Adhoc: Continental AG: Continental AG Sells ContiTech Group Sector

  • Published on 07/04/2026 at 09:05, 16 hours 34 minutes ago

    Velo x McLaren Mastercard Formula 1® Team Relaunches Live Your Fandom to Bring Fans Closer to the Sport They Love

  • Published on 07/03/2026 at 18:55, 1 day 6 hours ago

    Saudia Arabia's Mabani Aljazeera Group invests in Tatu City's Jabali Towers development

  • Published on 07/03/2026 at 18:14, 1 day 7 hours ago

    Fuller, Smith & Turner PLC: Transaction in own shares

View all EQS
Les Echos
  • Published on 07/03/2026 at 21:49, 1 day 3 hours ago

    Safran announces the end of negotiations regarding the contemplated acquisition of Exail Technologies.

  • Published on 07/03/2026 at 18:42, 1 day 6 hours ago

    Total number of voting rights and shares making up the share capital at June 30, 2026

  • Published on 07/03/2026 at 18:36, 1 day 7 hours ago

    Disclosure of transactions in own shares from July 1 to July 3, 2026

  • Published on 07/03/2026 at 18:00, 1 day 7 hours ago

    Half-year liquidity contract statement June 30, 2026

  • Published on 07/03/2026 at 17:54, 1 day 7 hours ago

    Mersen: Number of shares and voting rights as of June 30, 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy